Clinical trials
Phase 2 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
325 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2004 | 17 |
| 2005 | 13 |
| 2006 | 8 |
| 2007 | 28 |
| 2008 | 15 |
| 2009 | 12 |
| 2010 | 13 |
| 2011 | 14 |
| 2012 | 18 |
| 2013 | 13 |
| 2014 | 16 |
| 2015 | 11 |
| 2016 | 12 |
| 2017 | 10 |
| 2018 | 11 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 14 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 225 |
| Terminated | 34 |
| Recruiting | 17 |
| Unknown status | 15 |
| Active, not recruiting | 11 |
| Not yet recruiting | 10 |
| Withdrawn | 10 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 19 |
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| Novartis | 7 |
| University of Texas Southwestern Medical Center | 6 |
| Alcon Research | 5 |
| Meshalkin Research Institute of Pathology of Circulation | 5 |
| Alnylam Pharmaceuticals | 4 |
| Boehringer Ingelheim | 4 |
| Emory University | 4 |
| Ionis Pharmaceuticals, Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 325 |
| Cardiovascular Diseases | 30 |
| Obesity | 25 |
| Diabetes Mellitus | 22 |
| Diabetes Mellitus, Type 2 | 20 |
| Heart Diseases | 14 |
| Metabolic Syndrome | 14 |
| Renal Insufficiency, Chronic | 14 |
| Vascular Diseases | 13 |
| Essential Hypertension | 10 |
Trials
Showing 51 to 75 of 325. Each trial links to its page on Pharma Observatory.
225 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.